Biotech Investment Analyst – Drug Asset Assessment

About Open Train

Open Train is the #1 platform for finding and building careers in AI training and data labeling. Open Train AI is hiring and contracting for this role, helping specialists apply their expertise to projects that improve how advanced AI systems analyze complex information.

• Remote contractor opportunity
• Part-time schedule of less than 20 hours per week
• Paid pilot with potential for recurring engagement as the work scales

AI training is the human side of building artificial intelligence. Experts create examples, review model outputs, and develop evaluation standards that help AI systems produce more accurate and useful analysis. In this project, your biotech and investment expertise will help assess whether AI-generated reasoning about drug assets and companies is complete, well supported, and appropriately calibrated.

• Contribute to cutting-edge AI training work
• Use professional judgment to evaluate investment-style analysis
• Help identify weak, overconfident, or incomplete reasoning

Open Train is recruiting a Biotech Investment Analyst for a paid pilot focused on commercial drugs and drug-development programs. You will create and critique rubrics used to assess drug assets and the companies behind them, then apply those assessments across an approximate pilot set of 5-10 companies.

The work requires an end-to-end view of biotech and pharmaceutical opportunities, including mechanism, clinical data, competitive position, and value drivers. You will also judge the quality of investment-style theses and identify missing assumptions.

• Role type:
  Contractor and part time
• Location:
  
  United States
• Language:
  English
• Workload:
  Less than 20 hours per week
• Pay: $120-$200 USD per hour

You will help establish rigorous standards for evaluating biotech investment analysis. Your work will combine structured rubric creation with expert review of drug-development and company-level assessments.

• Create rubrics for analyzing commercial drugs and drug-development programs
• Critique rubrics for clarity, completeness, and analytical quality
• Assess companies and drug assets across mechanism, clinical data, competitive position, and value drivers
• Evaluate investment-style theses
• Flag weak, overconfident, or missing assumptions
• Apply your assessments to approximately 5-10 companies

This opportunity is intended for a US-based biotech or healthcare investment analyst with a specialist-fund background. You should be comfortable evaluating biotech or pharmaceutical companies and drug assets and assessing a drug asset end to end.

The structured listing classifies the opportunity as entry level, but the role requirements call for at least five years of experience evaluating biotech or pharma companies or assets.

• Based in the United States
• Biotech or healthcare investment analyst experience
• Specialist-fund background
• 5+ years evaluating biotech or pharma companies or drug assets
• Familiarity with biotech and pharmaceutical development programs
• Ability to assess mechanism, clinical data, competitive position, and value drivers
• Ability to create and critique analytical rubrics
• Skill in developing or evaluating investment-style theses
• Professional English proficiency

AI training offers a flexible way for specialists to contribute to the development of modern AI systems. Contributors apply real-world expertise to tasks such as writing, rating, and reviewing model outputs, often choosing work that fits around other professional or personal commitments.

• Work remotely with a computer and internet connection
• Choose a part-time workload of less than 20 hours per week
• Apply specialized biotech, healthcare, and investment knowledge
• Help shape how AI evaluates complex scientific and commercial questions